InvaGen Pharmaceuticals, Inc. · Central Islip, New York
Case #I-200-25199-186450
In FY2025, InvaGen Pharmaceuticals, Inc. sought H-1B sponsorship for a R&D Senior Analytical Scientist in Central Islip, New York at $105k per year, which is 12% above the prevailing wage of $94k. The case was certified in 27 days during the FY FY2025 cycle. This position is for continued employment.
| Case Number | I-200-25199-186450 |
| Case Status | Certified - Withdrawn |
| Visa Class | H-1B |
| Fiscal Year | FY 2025 |
| Employer | InvaGen Pharmaceuticals, Inc. |
| Employer Location | Warren, New Jersey |
| Job Title | R&D Senior Analytical Scientist |
| SOC Code | 19-104200 – Medical Scientists, Except Epidemiologists |
| Worksite | Central Islip, New York |
| Annual Wage | $105k |
| Prevailing Wage | $94k |
| Wage Premium | +11.7% |
| Positions | 1 (0 new, 0 continued) |
| Job Title | Salary | Status | Date |
|---|---|---|---|
| IT Specialist | $95k | CERTIFIED | Sep 23, 2025 |
| Facilities Engineer | $80k | CERTIFIED | Sep 23, 2025 |
| QC Chemist II | $81k | CERTIFIED | Aug 28, 2025 |
| Senior Scientist | $136k | CERTIFIED | Aug 20, 2025 |
| Associate Director, Quality Assurance | $120k | CERTIFIED | Aug 11, 2025 |
This Labor Condition Application (LCA) was filed by InvaGen Pharmaceuticals, Inc. for the position of R&D Senior Analytical Scientist in Central Islip, New York. The offered annual salary is $105k, compared to the prevailing wage of $94k for this occupation and location. This represents a wage premium of +11.7% above the prevailing wage.
The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.
Case status: Certified - Withdrawn. This means the employer or their representative withdrew the application.
A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.
When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, InvaGen Pharmaceuticals, Inc. filed LCA case number I-200-25199-186450 to sponsor a R&D Senior Analytical Scientist position at their worksite in Central Islip, New York. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.
The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:
For this filing, the offered wage of $105k compares to the DOL prevailing wage of $94k for Medical Scientists, Except Epidemiologists positions in the Central Islip, New York area. The positive wage premium of +11.7% indicates the employer is offering above the DOL-determined average for this occupation and location.
The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.
A "Certified-Withdrawn" status means this LCA was initially certified by the DOL but was later withdrawn by the employer. This can happen for various reasons: the foreign worker may have declined the position, found employment elsewhere, the employer may have decided to refile with updated information, or business conditions may have changed. A withdrawal does not negatively affect the employer's ability to file future LCAs.
This LCA was received by the DOL on Jul 18, 2025 and a decision was rendered on Aug 14, 2025, a processing time of approximately 27 business days. The standard DOL processing time for LCA applications is 7 to 10 business days. This application took longer than the standard timeframe, which may indicate additional review was required.
The offered salary of $105k for this R&D Senior Analytical Scientist position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 19-104200 (Medical Scientists, Except Epidemiologists), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.
The offered annual salary for this R&D Senior Analytical Scientist position at InvaGen Pharmaceuticals, Inc. is $105k. The Department of Labor prevailing wage for this occupation and location is $94k. The offered wage represents a +11.7% premium over the prevailing wage.
This H-1B filing is for a position located in Central Islip, New York. The employing company, InvaGen Pharmaceuticals, Inc., is headquartered in Warren, New Jersey.
This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.
The employer for this filing is InvaGen Pharmaceuticals, Inc., located in Warren, New Jersey. InvaGen Pharmaceuticals, Inc. filed this Labor Condition Application (case number I-200-25199-186450) for a R&D Senior Analytical Scientist position during fiscal year FY 2025. View all InvaGen Pharmaceuticals, Inc. H-1B filings.
Certified-Withdrawn means this LCA was initially certified by the DOL but was subsequently withdrawn by the employer or their authorized representative.